Healthcare shares are fairly flat in pre-market trade. STAAR
) says it received regulatory approval to market its Visian
Implantable Collamer Lens with CentraFLOW technology from the CDSCO
in India. STAA is flat at $11.27, having closed down 1% Friday.
And Cell Therapeutics (
) says the Transparency Commission of the French National Health
Authority has granted market access for PIXUVRI as a monotherapy to
treat adult patients with multiply relapsed or refractory
aggressive B-cell non-Hodgkin lymphoma. The next and final step in
France's pharmaceutical reimbursement process is inclusion on the
list of medicines approved for hospital use and subsequent
publication in the Journal Officiel in France, which CTIC now
intends to pursue.
Finally, StoneMor Partners (
) says it has acquired of Virginia based Forest Lawn Cemetery for
approximately $5 million in cash. Forest Lawn, located in Richmond,
Virginia, currently handles an average of more than 500 interments
per year and is expected to continue to operate under the Forest
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.